A61P 9/06
Antiarrhythmics
A61P9/06 (Antiarrhythmics) appears on 3,627 US grants and 4,641 published applications in this corpus.
Search patents in A61P- Granted patents
- 3,627
- Published applications
- 4,641
- Assignees
- 1,432
- Inventors
- 8,687
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 10 | 0 |
| 1978 | 16 | 0 |
| 1979 | 16 | 0 |
| 1980 | 17 | 0 |
| 1981 | 23 | 0 |
| 1982 | 21 | 0 |
| 1983 | 17 | 0 |
| 1984 | 26 | 0 |
| 1985 | 41 | 0 |
| 1986 | 38 | 0 |
| 1987 | 38 | 0 |
| 1988 | 39 | 0 |
| 1989 | 49 | 0 |
| 1990 | 47 | 0 |
| 1991 | 48 | 0 |
| 1992 | 38 | 0 |
| 1993 | 17 | 0 |
| 1994 | 20 | 0 |
| 1995 | 30 | 0 |
| 1996 | 23 | 0 |
| 1997 | 51 | 0 |
| 1998 | 46 | 0 |
| 1999 | 48 | 0 |
| 2000 | 50 | 0 |
| 2001 | 63 | 17 |
| 2002 | 78 | 106 |
| 2003 | 86 | 170 |
| 2004 | 72 | 255 |
| 2005 | 78 | 221 |
| 2006 | 113 | 211 |
| 2007 | 102 | 253 |
| 2008 | 109 | 286 |
| 2009 | 101 | 282 |
| 2010 | 178 | 374 |
| 2011 | 194 | 299 |
| 2012 | 178 | 323 |
| 2013 | 207 | 221 |
| 2014 | 220 | 222 |
| 2015 | 210 | 218 |
| 2016 | 155 | 176 |
| 2017 | 135 | 181 |
| 2018 | 123 | 135 |
| 2019 | 100 | 149 |
| 2020 | 80 | 121 |
| 2021 | 72 | 90 |
| 2022 | 59 | 82 |
| 2023 | 35 | 78 |
| 2024 | 39 | 71 |
| 2025 | 42 | 65 |
| 2026 | 20 | 35 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds, compositions, and methods for modulating calcium ion homeostasis8 Sep 2026US 12,729,181 B2The Regents of the University of California
- Modulators of the integrated stress response pathway25 Aug 2026US 12,715,865 B2Evotec International GmbH
- Anti-IL-1β antibody therapy in arrhythmogenic cardiomyopathy (ACM)18 Aug 2026US 12,708,665 B2Beth Israel Deaconess Medical Center, Inc.
- Methods for initiating sotalol21 Jul 2026US 12,685,716 B1
- Targeting peptides for directing adeno-associated viruses (AAVs)16 Jun 2026US 12,653,904 B2California Institute of Technology
- Antiarrhythmic formulation27 Aug 2026US 2026/0248776 A1InCarda Therapeutics, Inc.
- Micronutrient pharmaceutical composition for bioenergy stimulation for mammal27 Aug 2026US 2026/0248843 A1
- Agents and methods for treating myopathies20 Aug 2026US 2026/0242502 A1Belth Israel Deaconess Medical Center. Inc.
- Treatment methods having reduced drug-related toxicity and methods of identifying the likelihood of patient harm from prescribed medications13 Aug 2026US 2026/0235578 A1Tabula Rasa Healthcare, Inc.
- Injectable compositions of flecainide30 Jul 2026US 2026/0216160 A1Cipla Limited
Most cited
By later US patents
- Gum pad for delivery of medication to mucosal tissues1,140US 6,319,510 B12001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Controlled release bases for pharmaceuticals383US 4,861,598 AEuroceltique, S.A. · 1989